Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1959 2
1961 4
1962 1
1963 3
1964 4
1965 5
1966 3
1967 4
1968 6
1969 5
1970 4
1971 9
1972 9
1973 5
1974 11
1975 9
1976 6
1977 10
1978 16
1979 11
1980 7
1981 8
1982 8
1983 15
1984 14
1985 7
1986 14
1987 17
1988 13
1989 17
1990 26
1991 22
1992 32
1993 33
1994 24
1995 43
1996 43
1997 61
1998 65
1999 69
2000 87
2001 95
2002 76
2003 105
2004 115
2005 142
2006 151
2007 175
2008 186
2009 209
2010 254
2011 331
2012 413
2013 438
2014 449
2015 524
2016 610
2017 637
2018 669
2019 781
2020 964
2021 1093
2022 1293
2023 640

Text availability

Article attribute

Article type

Publication date

Search Results

9,989 results

Results by year

Filters applied: . Clear all
Page 1
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance.
Lin M, Zhang XL, You R, Liu YP, Cai HM, Liu LZ, Liu XF, Zou X, Xie YL, Zou RH, Zhang YN, Sun R, Feng WY, Wang HY, Tao GH, Li HJ, Huang WJ, Zhang C, Huang PY, Wang J, Zhao Q, Yang Q, Zhang HW, Liu T, Li HF, Jiang XB, Tang J, Gu YK, Yu T, Wang ZQ, Feng L, Kang TB, Zuo ZX, Chen MY. Lin M, et al. Among authors: huang py. Nat Commun. 2023 Feb 4;14(1):610. doi: 10.1038/s41467-023-35995-2. Nat Commun. 2023. PMID: 36739462 Free PMC article.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group. Blanchard P, et al. Among authors: huang py. Lancet Oncol. 2015 Jun;16(6):645-55. doi: 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6. Lancet Oncol. 2015. PMID: 25957714
Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
Zhang Q, Zhu F, Shi G, Hu C, Zhang W, Huang P, Zhu C, Gu H, Yang D, Li Q, Niu Y, Chen H, Ma R, Pan Z, Miao H, Zhang X, Li G, Tang Y, Qiao G, Yan Y, Zhu Z, Zhang H, Han F, Li Y, Lin J, Chen H. Zhang Q, et al. Among authors: huang p. Circulation. 2023 Feb 14;147(7):549-561. doi: 10.1161/CIRCULATIONAHA.122.057987. Epub 2023 Feb 13. Circulation. 2023. PMID: 36780387
Editorial: Neuroimaging study of post-stroke cerebral edema.
Zhang S, Zhu C, Broocks G, Huang P, Blair C. Zhang S, et al. Among authors: huang p. Front Neurol. 2023 Mar 7;14:1167275. doi: 10.3389/fneur.2023.1167275. eCollection 2023. Front Neurol. 2023. PMID: 36959828 Free PMC article. No abstract available.
The biology and treatment of leiomyosarcomas.
Kerrison WGJ, Thway K, Jones RL, Huang PH. Kerrison WGJ, et al. Among authors: huang ph. Crit Rev Oncol Hematol. 2023 Apr;184:103955. doi: 10.1016/j.critrevonc.2023.103955. Epub 2023 Mar 7. Crit Rev Oncol Hematol. 2023. PMID: 36893945 Free article. Review.
Boosting Checkpoint Immunotherapy with Biomaterials.
Liu L, Pan Y, Zhao C, Huang P, Chen X, Rao L. Liu L, et al. Among authors: huang p. ACS Nano. 2023 Feb 28;17(4):3225-3258. doi: 10.1021/acsnano.2c11691. Epub 2023 Feb 6. ACS Nano. 2023. PMID: 36746639 Review.
Proton-Activated Chloride Channel: Physiology and Disease.
Peng F, Wu Y, Dong X, Huang P. Peng F, et al. Among authors: huang p. Front Biosci (Landmark Ed). 2023 Jan 16;28(1):11. doi: 10.31083/j.fbl2801011. Front Biosci (Landmark Ed). 2023. PMID: 36722267 Free article. Review.
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R, Liu YP, Xie YL, Lin C, Duan CY, Chen DP, Pan Y, Qi B, Zou X, Guo L, Cao JY, Zhang YN, Wang ZQ, Liu YL, Ouyang YF, Wen K, Yang Q, Xie RQ, Li HF, Duan XT, Ding X, Peng L, Chen SY, Liang JL, Feng ZK, Xia TL, Xie RL, Jiang R, Gu CM, Liu RZ, Sun R, Yang X, Liu LZ, Ling L, Liu Q, Ng WT, Hua YJ, Huang PY, Chen MY. You R, et al. Among authors: huang py. Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23. Lancet. 2023. PMID: 36842439 Clinical Trial.
9,989 results